Kate Tolo’s journey to becoming the ultimate female self-tracker is as gruelling as it is groundbreaking. From her early days of silence around menstruation to her current role as the centrepiece of a $2.6 million health-tech experiment, her story is a testament to the power of personal data and the quest for female empowerment.

Johnson’s vision is ambitious: to develop non-invasive methods for diagnosing and treating endometriosis, a condition affecting 10% of women. Through rigorous tracking and innovative lab work, Tolo aims to make diagnosis as simple as a saliva test. It’s a stark contrast to the invasive procedures traditionally required, offering hope for a future where women can embrace their cycles without fear.

While Tolo’s dedication is admirable, it’s also a reminder of the barriers women face in healthcare. Her refusal to undergo surgery initially and her panic attacks highlight the mental toll of such intense tracking. Yet, despite the discomfort, Tolo’s mission is clear: to help other women who have faced similar struggles. Her work could pave the way for a new era of female self-care and medical innovation.

The world of biotech and self-tracking is increasingly pushing the boundaries of what’s possible. Tolo and Johnson’s project could disrupt traditional diagnostic methods, making them more accessible and less invasive. However, as with any bold new approach, there are concerns about the accuracy and reliability of the methods they are developing. Time will tell if their efforts will transform healthcare for the better.